Clinical Trial

Prevention of Oxaliplatin-induced Nerve Damage in the Body's Extremities

Study acronym: OxaNeuro
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to examine the effect of supplementary polyunsaturated fatty acids on nerve damage in the body's extremitites of patients treated with oxaliplatin containing chemotherapy after surgery for colorectal cancer.
Protocol Amendment History 3 changes
notable Trial sites expanded: 1 -> 4 locations 2026-05-20
notable Primary completion pushed: 2026-05 -> 2027-12 2026-05-20
minor Completion pushed: 2026-12 -> 2028-12 2026-05-20
Trial Details
NCT Number NCT05404230
Lead Sponsor Vejle Hospital
Conditions Peripheral Neuropathy, Colorectal Cancer
Enrollment 120 participants
Start Date 2022-07-15
Primary Completion 2027-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-19